Clinical Trial Update: Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy, immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy female participants. Recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Genital Warts
• Vaginal Cancer
• Vaginal Intraepithelial Neoplasia
• Vulvar Cancer
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• 9-valent HPV recombinant vaccine

Snippet

Sponsor: Shanghai Bovax Biotechnology Co., Ltd. | Conditions: Cervical Cancer, Vulvar Cancer | Phase 3 | Status: RECRUITING